首页 > 产品中心 > 抗体 > 药物对照抗体

Research Grade Navicixizumab (HV571036)

价格:
规格:
  • 100ug
  • 1mg
数量:
  • 概述
  • 图片
  • 参考文献
  • 产品说明书
概述
货号HV571036
品牌abinScience
种属反应性Human
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
宿主Humanized
同种型IgG2-kappa
表达系统Mammalian Cells
克隆类型Monoclonal
靶标Delta-like protein 4, Drosophila Delta homolog 4, Delta4, DLL4, Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A
内毒素水平Please contact the lab for this information.
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
Accession号Q9NR61 & P15692
状态Liquid
保存溶液0.01M PBS, pH 7.4.
稳定性和存储Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
别名Bispecific, OMP-305B83, 1638338-43-8
背景Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer.
NoteFor research use only. Not suitable for clinical or therapeutic use.
图片
  • SEC-HPLC

    SEC-HPLC detection for Research Grade Navicixizumab.

  • Bioactivity

    Detects DLL4 in indirect ELISAs.

参考文献

相关产品推荐